Silver Book Fact

Medicare spending for those with Alzheimer’s disease will triple by 2015–to $189 billion from $62 billion in 2000. By 2050, Medicare will be spending more than $1 trillion on beneficiaries with Alzheimer’s disease and related dementias.

The Lewin Group. Saving Lives, Saving Money: Dividends for Americans investing in Alzheimer research. Falls Church, VA: The Lewin Group; 2004

Reference

Title
Saving Lives, Saving Money: Dividends for Americans investing in Alzheimer research
Publisher
The Lewin Group
Publication Date
2004
Authors
The Lewin Group

Categories

  • Cost of Disease
  • Future Economic Burden

Related Facts

  • Parkinson’s disease is the 2nd-most common neurodegenerative disease in the U.S., second only to Alzheimer’s disease.  
  • Therapeutic surgery for those with Parkinson’s can cost approximately $100,000 per patient.  
  • Alzheimer’s Disease is the most common type of dementia; it accounts for an estimated 60 to 80 percent of cases.  
  • Of the 5.2 million people over age 65 with Alzheimer’s in the United States, 3.4 million are women and 1.8 million are men.  
  • Medicaid Nursing Home Costs, Delayed Onset